Resveratrol Induces Endothelial Progenitor Cells Angiogenesis Via MiR-542-3p by Targeting Angiopoietin-2 and Involves in Recanalization of Venous Thrombosis

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2019 Oct 14

PMID 31606730

Citations 11

Authors

Zhen Lu

Shuanhu Wang

Xingyang Zhu

Xiao Yuan

Yanqing Zhan

Yongsheng Li

Wenbin Wang

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Endothelial progenitor cells (EPCs) play an important role in therapeutic angiogenesis. Besides, resveratrol (RSV) exerts many pharmacological functions in regulation of cell function. Furthermore, microRNAs (miRNAs) have been considered to be of great significance in biological process. In this study, we aimed to investigate the effect of RSV on EPCs and its potential mechanism that involved in recanalization of venous thrombosis. MATERIAL AND METHODS EPCs were treated with RSV, and angiogenic functions was evaluated by tube formation and migration assays. miR-542-3p expression level in EPCs was assessed and exogenously modified. Bioinformatic analysis was applied to detect the potential target of miR-542-3p. Effects of RSV treatment in vivo venous thrombosis rat model were evaluated. RESULTS RSV enhanced angiogenic function of EPCs and decreased expression of miR-542-3p. Dual luciferase reporter gene and western blot results confirmed angiopoietin-2 (ANGPT2) was a direct target of miR-542-3p. It was found that inhibition of miR-542-3p contributed to angiogenesis of EPCs and elevated ANGPT2 protein level. Finally, in a rat model of venous thrombosis, RSV-treated EPCs promoted recanalization of thrombi. CONCLUSIONS We demonstrated that RSV can contribute to progenitor cells angiogenesis via miR-542-3p by targeting ANGPT2, subsequently enhanced recanalization of thrombi.

Citing Articles

Exosomes in nanomedicine: a promising cell-free therapeutic intervention in burn wounds.

Manzoor T, Farooq N, Sharma A, Shiekh P, Hassan A, Dar L Stem Cell Res Ther. 2024; 15(1):355.

PMID: 39385310 PMC: 11462792. DOI: 10.1186/s13287-024-03970-3.

Exosomal microRNA-Based therapies for skin diseases.

Jibing C, Weiping L, Yuwei Y, Bingzheng F, Zhiran X Regen Ther. 2024; 25:101-112.

PMID: 38178928 PMC: 10765304. DOI: 10.1016/j.reth.2023.12.005.

Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation.

Sun L, Liu Z, Ran F, Huang D, Zhang M, Li X Stem Cell Res Ther. 2024; 15(1):7.

PMID: 38169418 PMC: 10762949. DOI: 10.1186/s13287-023-03621-z.

Resveratrol Reverses Endothelial Colony-Forming Cell Dysfunction in Adulthood in a Rat Model of Intrauterine Growth Restriction.

Guillot E, Lemay A, Allouche M, Vitorino Silva S, Coppola H, Sabatier F Int J Mol Sci. 2023; 24(11).

PMID: 37298697 PMC: 10253508. DOI: 10.3390/ijms24119747.

Downregulation of miR-125a-5p Promotes Endothelial Progenitor Cell Migration and Angiogenesis and Alleviates Deep Vein Thrombosis in Mice Via Upregulation of MCL-1.

Yu J, Jin Y, Xu C, Fang C, Zhang Z, Chen L Mol Biotechnol. 2023; 65(10):1664-1678.

PMID: 36738360 DOI: 10.1007/s12033-023-00676-4.

References

He T, Smith L, Harrington S, Nath K, Caplice N, Katusic Z . Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke. 2004; 35(10):2378-84. DOI: 10.1161/01.STR.0000141893.33677.5d. View

Mazzieri R, Pucci F, Moi D, Zonari E, Ranghetti A, Berti A . Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell. 2011; 19(4):512-26. DOI: 10.1016/j.ccr.2011.02.005. View

Breen D, Dolinsky V, Zhang H, Ghanim H, Guo J, Mroziewicz M . Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism. Atherosclerosis. 2012; 222(2):375-81. DOI: 10.1016/j.atherosclerosis.2012.03.021. View

Althoff K, Lindner S, Odersky A, Mestdagh P, Beckers A, Karczewski S . miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer. 2014; 136(6):1308-20. DOI: 10.1002/ijc.29091. View

Yuan L, Yuan P, Yuan H, Wang Z, Run Z, Chen G . miR-542-3p inhibits colorectal cancer cell proliferation, migration and invasion by targeting OTUB1. Am J Cancer Res. 2017; 7(1):159-172. PMC: 5250690. View

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

Kureel J, Dixit M, Tyagi A, Mansoori M, Srivastava K, Raghuvanshi A . miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation. Cell Death Dis. 2014; 5:e1050. PMC: 3944264. DOI: 10.1038/cddis.2014.4. View

Bae S, Lee E, Cha H, Kim K, Yoon Y, Lee H . Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol Cells. 2011; 32(3):243-9. PMC: 3887628. DOI: 10.1007/s10059-011-1037-z. View

Xia L, Wang X, Hu X, Guo X, Shang Y, Chen H . Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol. 2008; 155(3):387-94. PMC: 2567879. DOI: 10.1038/bjp.2008.272. View

10.

He T, Qi F, Jia L, Wang S, Song N, Guo L . MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2. J Pathol. 2014; 232(5):499-508. DOI: 10.1002/path.4324. View

11.

Campagnolo P, Hong X, Di Bernardini E, Smyrnias I, Hu Y, Xu Q . Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models. PLoS One. 2015; 10(5):e0125122. PMC: 4427364. DOI: 10.1371/journal.pone.0125122. View

12.

Modarai B, Burnand K, Sawyer B, Smith A . Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation. 2005; 111(20):2645-53. DOI: 10.1161/CIRCULATIONAHA.104.492678. View

13.

Shen X, Wang M, Bi X, Zhang J, Wen S, Fu G . Resveratrol prevents endothelial progenitor cells from senescence and reduces the oxidative reaction via PPAR‑γ/HO‑1 pathways. Mol Med Rep. 2016; 14(6):5528-5534. PMC: 5355720. DOI: 10.3892/mmr.2016.5929. View

14.

Weiler J, Hunziker J, Hall J . Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?. Gene Ther. 2005; 13(6):496-502. DOI: 10.1038/sj.gt.3302654. View

15.

J G, Cq W, Hh F, Hy D, Xl X, Ym X . Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J Cardiovasc Pharmacol. 2006; 47(5):711-21. DOI: 10.1097/01.fjc.0000211764.52012.e3. View

16.

He T, Qi F, Jia L, Wang S, Wang C, Song N . Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p. Cancer Lett. 2015; 368(1):115-125. DOI: 10.1016/j.canlet.2015.07.036. View

17.

Dhar S, Kumar A, Rimando A, Zhang X, Levenson A . Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget. 2015; 6(29):27214-26. PMC: 4694984. DOI: 10.18632/oncotarget.4877. View

18.

Krenning G, van Luyn M, Harmsen M . Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med. 2009; 15(4):180-9. DOI: 10.1016/j.molmed.2009.02.001. View

19.

Raskob G, Angchaisuksiri P, Blanco A, Buller H, Gallus A, Hunt B . Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014; 34(11):2363-71. DOI: 10.1161/ATVBAHA.114.304488. View

20.

Lyu H, Wang S, Huang J, Wang B, He Z, Liu B . Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer. Cancer Lett. 2018; 420:97-108. PMC: 6089084. DOI: 10.1016/j.canlet.2018.01.065. View